查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555648

迷走神经刺激市场：2024-2031年全球产业分析、规模、占有率、成长、趋势、预测

Vagus Nerve Stimulation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 181 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份有关全球迷走神经刺激（VNS）市场的详细报告。本报告对市场驱动因素、趋势、机会和挑战等关键市场动态进行了全面分析，提供了对市场结构的深入见解。

主要见解

  • 迷走神经刺激疗法市场规模（2024年）：5.659亿美元
  • 预测市场规模（2031年）：7.831亿美元
  • 全球市场成长率（2024-2031年年复合成长率）：8.5%

迷走神经刺激市场 - 报告范围：

迷走神经刺激市场涵盖用于非侵入性和植入性刺激迷走神经的装置。这些设备已广泛用于治疗传统疗法无效的神经系统疾病，例如癫痫和忧郁症。该市场服务于各种医疗保健环境，包括医院、诊所和家庭医疗保健。神经系统疾病盛行率不断上升以及 VNS 设备技术进步改善了治疗效果，推动了市场成长。扩展到新兴市场、扩大其他治疗领域的应用以及对非侵入性医疗保健解决方案不断成长的需求促进市场的强劲成长。

推动市场成长的因素：

迷走神经刺激的全球市场主要是由癫痫、忧郁症和偏头痛等神经系统疾病发病率的增加所推动的。 VNS疗法在传统治疗失败时显示出疗效，并已成为医疗保健领域的重要选择。技术进步，尤其是 VNS 设备中人工智慧（AI）和机器学习的整合，实现个人化治疗计划，进一步推动市场发展。此外，VNS 疗法在慢性心臟衰竭和肥胖等疾病中的广泛应用开闢新的成长途径。

市场限制因素：

儘管 VNS 市场潜力巨大，但仍面临一些挑战。医疗保健专业人员和患者对迷走神经刺激疗法的益处认识有限可能会阻碍市场成长。此外，与植入式设备相关的高成本和手术问题也减少了患者的采用。医疗器材审批的监管障碍和严格要求进一步减缓了市场进入，特别是在新兴市场。 VNS 在不同疾病状态下使用的标准化方案的缺乏也限制了 VNS 的广泛接受。

市场机会：

VNS 市场提供了巨大的机会，特别是在对先进神经治疗方案的需求不断增加的新兴国家。非侵入性 VNS 设备的开发以及神经系统疾病以外的应用扩展是主要的成长领域。医疗保健提供者和 VNS 设备製造商之间的合作可以进一步加速市场渗透。家庭医疗保健趋势和电子商务平台上设备可用性的增加也推动了 VNS 治疗的更广泛普及，并支持未来的市场扩张。

本报告涵盖的主要问题

  • 推动迷走神经刺激市场全球成长的关键因素是什么？
  • 哪些类型的VNS 设备在各种环境中的采用率领先？
  • 技术进步如何影响 VNS 市场的竞争格局？
  • 谁是 VNS 市场的主要参与者？ 他们采取什么策略来保持竞争力？
  • 全球迷走神经刺激市场有哪些新趋势与未来前景？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 课题
    • 主要趋势
  • 宏观经济因素
    • 世界产业展望
    • 世界 GDP 成长前景
    • 全球医疗保健支出前景
  • 新冠肺炎（COVID-19）影响分析
  • 预测因子 - 相关性和影响

第3章 增值见解

  • 产品采用率分析
  • 技术评估
  • 监理状况
  • 价值链分析
  • 主要交易和合併
  • PESTLE分析
  • 波特五力分析

第4章 2019-2031年价格趋势分析

  • 主要亮点
  • 影响产品价格的主要因素
  • 以产品进行价格分析
  • 区域价格与产品偏好

第5章 全球迷走神经刺激市场展望：过去（2019-2023年）与预测（2024-2031年）

  • 主要亮点
    • 市场规模（数量）预测
    • 市场规模（金额）及年比成长率
    • 绝对的机会
  • 市场规模（金额）分析与预测
    • 过去的市场规模（金额）分析，2019-2023年
    • 2023-2031年目前市场规模（金额）分析与预测
  • 全球迷走神经刺激市场展望：产品
    • 简介/主要调查结果
    • 过去的市场规模（金额和数量）分析，2019-2023年
    • 2024-2031年当前市场规模（金额和数量）分析与预测
      • 嵌入式 VNS 设备
      • 外部 VNS 设备
  • 市场吸引力分析：产品
  • 全球迷走神经刺激市场展望：生物材料
    • 简介/主要调查结果
    • 过去的市场规模（金额）分析，2019-2023年
    • 2024-2031年目前市场规模（金额）分析与预测
      • 金属
      • 陶瓷
      • 聚合物
  • 市场吸引力分析：生物材料
  • 全球迷走神经刺激市场展望：应用
    • 简介/主要调查结果
    • 过去的市场规模（金额）分析，2019-2023年
    • 2024-2031年目前市场规模（金额）分析与预测
      • 癫痫
      • 忧郁症
      • 偏头痛
  • 市场吸引力分析：应用

第6章 全球迷走神经刺激市场展望：地区

  • 主要亮点
  • 过去的市场规模（金额和数量）分析，2019-2023年
  • 2024-2031年当前市场规模（金额和数量）分析与预测
    • 北美
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东、非洲
  • 市场吸引力分析：地区

第7章 北美迷走神经刺激市场展望：过去（2019-2023）与预测（2024-2031）

第8章 欧洲迷走神经刺激市场展望：过去（2019-2023年）与预测（2024-2031年）

第9章 东亚迷走神经刺激市场展望：过去（2019-2023年）与预测（2024-2031年）

第10章 南亚与大洋洲迷走神经刺激市场展望：过去（2019-2023）与预测（2024-2031）

第11章 拉丁美洲迷走神经刺激市场展望：过去（2019-2023年）与预测（2024-2031年）

第12章 中东与非洲迷走神经刺激市场展望：过去（2019-2023）与预测（2024-2031）

第13章 竞争态势

  • 2023年市占率分析
  • 市场结构
    • 依市场划分的竞争强度图
    • 竞争仪表板
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Soterix Medical Inc.
    • MicroTransponder Inc
    • Beijing PINS Medical Co., Ltd
    • LivaNova PLC
    • Neuropix Company Ltd.
    • Parasym Ltd
    • electroCore, Inc.
    • tVNS Health GmbH
    • SetPoint Medical Corporation

第14章 附录

  • 调查方法
  • 调查的先决条件
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP34750

Persistence Market Research has recently published an extensive report on the global Vagus Nerve Stimulation (VNS) Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Vagus Nerve Stimulation Market Size (2024E): USD 565.9 Mn
  • Projected Market Value (2031F): USD 783.1 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 8.5%

Vagus Nerve Stimulation Market - Report Scope:

The Vagus Nerve Stimulation Market covers devices used for non-invasive and implantable stimulation of the vagus nerve. These devices have been widely employed in treating neurological disorders such as epilepsy and depression, where conventional treatments have not been effective. The market caters to different healthcare settings, including hospitals, clinics, and home care. Market growth is driven by the rising prevalence of neurological conditions and technological advancements in VNS devices that offer improved treatment outcomes. Expansion into emerging markets, growing applications in other therapeutic areas, and increasing demand for non-invasive healthcare solutions contribute to the market's robust growth.

Market Growth Drivers:

The global Vagus Nerve Stimulation Market is primarily driven by the increasing incidence of neurological disorders such as epilepsy, depression, and migraines. VNS therapy has shown effectiveness in cases where traditional treatments have failed, making it a crucial option in the healthcare sector. Technological advancements, particularly the integration of artificial intelligence (AI) and machine learning in VNS devices, allow personalized treatment plans, further propelling the market. Additionally, expanding applications of VNS therapy to conditions such as chronic heart failure and obesity are opening new growth avenues.

Market Restraints:

Despite its potential, the VNS market faces several challenges. Limited awareness among healthcare professionals and patients regarding the benefits of VNS therapy can hinder market growth. Additionally, high costs associated with implantable devices and concerns about surgical procedures reduce patient adoption. Regulatory barriers and stringent requirements for medical device approvals further delay market entry, particularly in emerging markets. A lack of standardized protocols for the use of VNS across different conditions also restricts its broader acceptance.

Market Opportunities:

The VNS market presents significant opportunities, especially in emerging economies where the demand for advanced neurological treatment options is rising. The development of non-invasive VNS devices and expanding applications beyond neurological disorders represent key growth areas. Collaborations between healthcare providers and VNS device manufacturers can further accelerate market penetration. The growing trend of home healthcare and the increasing availability of devices through e-commerce platforms are also facilitating wider access to VNS therapy, driving future market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Vagus Nerve Stimulation Market globally?
  • Which types of VNS devices are leading the adoption in various settings?
  • How are technological advancements influencing the competitive landscape of the VNS market?
  • Who are the key players in the VNS market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Vagus Nerve Stimulation Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Vagus Nerve Stimulation Market are focusing on product innovation, technological advancements, and strategic partnerships. Companies are investing in research and development to enhance the efficacy and accessibility of VNS devices. Collaborations with healthcare institutions and partnerships with governments to introduce devices in emerging economies help expand market reach. As healthcare providers recommend VNS therapy for a broader range of conditions, product differentiation and quality assurance will be crucial for maintaining a competitive edge in the market.

Key Market Players

  • Soterix Medical Inc.
  • MicroTransponder Inc
  • Beijing PINS Medical Co., Ltd
  • LivaNova PLC
  • Neuropix Company Ltd.
  • Parasym Ltd
  • electroCore, Inc.
  • tVNS Health GmbH
  • SetPoint Medical Corporation

Vagus Nerve Stimulation Industry Segmentation

By Product

  • Implantable VNS Device
  • External VNS Device

By Biomaterial

  • Metallic
  • Ceramics
  • Polymeric

By Application

  • Epilepsy
  • Depression
  • Migraine

By Region

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • East Asia
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Vagus Nerve Stimulation Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Technology Assessment
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2031

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
  • 5.3. Global Vagus Nerve Stimulation Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2023
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
      • 5.3.3.1. Implantable VNS Device
      • 5.3.3.2. External VNS Device
  • 5.4. Market Attractiveness Analysis: Product
  • 5.5. Global Vagus Nerve Stimulation Market Outlook: Biomaterial
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Biomaterial, 2019-2023
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
      • 5.5.3.1. Metallic
      • 5.5.3.2. Ceramics
      • 5.5.3.3. Polymeric
  • 5.6. Market Attractiveness Analysis: Biomaterial
  • 5.7. Global Vagus Nerve Stimulation Market Outlook: Application
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
    • 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
      • 5.7.3.1. Epilepsy
      • 5.7.3.2. Depression
      • 5.7.3.3. Migraine
  • 5.8. Market Attractiveness Analysis: Application

6. Global Vagus Nerve Stimulation Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2023
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2024-2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Biomaterial
    • 7.3.4. By Application
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 7.4.1. U.S.
    • 7.4.2. Canada
  • 7.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 7.5.1. Implantable VNS Device
    • 7.5.2. External VNS Device
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 7.6.1. Metallic
    • 7.6.2. Ceramics
    • 7.6.3. Polymeric
  • 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 7.7.1. Epilepsy
    • 7.7.2. Depression
    • 7.7.3. Migraine
  • 7.8. Market Attractiveness Analysis

8. Europe Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Biomaterial
    • 8.3.4. By Application
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. U.K.
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Russia
    • 8.4.7. Turkey
    • 8.4.8. Rest of Europe
  • 8.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 8.5.1. Implantable VNS Device
    • 8.5.2. External VNS Device
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 8.6.1. Metallic
    • 8.6.2. Ceramics
    • 8.6.3. Polymeric
  • 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 8.7.1. Epilepsy
    • 8.7.2. Depression
    • 8.7.3. Migraine
  • 8.8. Market Attractiveness Analysis

9. East Asia Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Biomaterial
    • 9.3.4. By Application
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. South Korea
  • 9.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 9.5.1. Implantable VNS Device
    • 9.5.2. External VNS Device
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 9.6.1. Metallic
    • 9.6.2. Ceramics
    • 9.6.3. Polymeric
  • 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 9.7.1. Epilepsy
    • 9.7.2. Depression
    • 9.7.3. Migraine
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Biomaterial
    • 10.3.4. By Application
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 10.4.1. India
    • 10.4.2. Southeast Asia
    • 10.4.3. ANZ
    • 10.4.4. Rest of South Asia & Oceania
  • 10.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 10.5.1. Implantable VNS Device
    • 10.5.2. External VNS Device
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 10.6.1. Metallic
    • 10.6.2. Ceramics
    • 10.6.3. Polymeric
  • 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 10.7.1. Epilepsy
    • 10.7.2. Depression
    • 10.7.3. Migraine
  • 10.8. Market Attractiveness Analysis

11. Latin America Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Biomaterial
    • 11.3.4. By Application
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 11.5.1. Implantable VNS Device
    • 11.5.2. External VNS Device
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 11.6.1. Metallic
    • 11.6.2. Ceramics
    • 11.6.3. Polymeric
  • 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 11.7.1. Epilepsy
    • 11.7.2. Depression
    • 11.7.3. Migraine
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Biomaterial
    • 12.3.4. By Application
  • 12.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 12.4.1. GCC Countries
    • 12.4.2. Egypt
    • 12.4.3. South Africa
    • 12.4.4. Northern Africa
    • 12.4.5. Rest of Middle East & Africa
  • 12.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 12.5.1. Implantable VNS Device
    • 12.5.2. External VNS Device
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 12.6.1. Metallic
    • 12.6.2. Ceramics
    • 12.6.3. Polymeric
  • 12.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 12.7.1. Epilepsy
    • 12.7.2. Depression
    • 12.7.3. Migraine
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Soterix Medical Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. MicroTransponder Inc
    • 13.3.3. Beijing PINS Medical Co., Ltd
    • 13.3.4. LivaNova PLC
    • 13.3.5. Neuropix Company Ltd.
    • 13.3.6. Parasym Ltd
    • 13.3.7. electroCore, Inc.
    • 13.3.8. tVNS Health GmbH
    • 13.3.9. SetPoint Medical Corporation

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations